SPECIFIC INTERFERENCE WITH NUCLEAR ERK1/2 SIGNALING PREVENTS PATHOLOGICAL CARDIAC HYPERTROPHY

被引：0
|
作者：
Ruppert, C. [1 ,2 ]
Deiss, K. [1 ]
Herrmann, S. [2 ,3 ]
Vidal, M. [1 ]
Oezkur, M. [2 ,4 ]
Gorski, A. [2 ,4 ]
Weidemann, F. [2 ,3 ]
Lohse, M. J. [1 ,2 ]
Lorenz, K. [1 ,2 ]
机构：
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany
[2] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany
[4] Univ Hosp Wurzburg, Dept Thorac Cardiac & Thorac Vasc Surg, Wurzburg, Germany
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [1] Selective interference with nuclear ERK1/2 signaling prevents pathological cardiac hypertrophy
    Ruppert, C.
    Vidal, M.
    Lohse, M. J.
    Lorenz, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S68 - S68
  • [2] Inhibition of ERK dimerization prevents the development of ERK1/2-mediated cardiac hypertrophy
    Huemmert, M.
    Vidal, M.
    Schmitt, J. P.
    Lohse, M. J.
    Lorenz, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 26 - 26
  • [3] A novel modification of ERK1/2 results in hypertrophy specific signaling
    Lorenz, K.
    Schmitt, J. P.
    Schmitteckert, E. M.
    Maier-Peuschel, M.
    Quitterer, U.
    Lohse, M. J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 54 - 54
  • [4] Monomeric ERK2 attenuates ERK1/2-mediated pathological cardiac hypertrophy
    Tomasovic, Angela
    Huemmert, Martin
    Ruppert, Catharina
    Lohse, Martin J.
    Lorenz, Kristina
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S20 - S20
  • [5] Cardiac hypertrophy: Targeting Raf/MEK/ERK1/2-signaling
    Lorenz, Kristina
    Schmitt, Joachim P.
    Vidal, Marie
    Lohse, Martin J.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (12): : 2351 - 2355
  • [6] Characterization of a peptide that interferes with ERK1/2-mediated pathological cardiac hypertrophy
    Tomasovic, A.
    Huemmert, M.
    Ruppert, C.
    Lorenz, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S41 - S41
  • [7] A new potential strategy for targeting pathological cardiac hypertrophy: the dimer interface of ERK1/2
    Tomasovic, A.
    Huemmert, M.
    Lorenz, K. Kristina
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 432 - 432
  • [8] Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy
    Kehat, Izhak
    Molkentin, Jeffery D.
    ANALYSIS OF CARDIAC DEVELOPMENT: FROM EMBRYO TO OLD AGE, 2010, 1188 : 96 - 102
  • [9] CREG, a new regulator of ERK1/2 in cardiac hypertrophy
    Xu, L
    Liu, JM
    Chen, LY
    JOURNAL OF HYPERTENSION, 2004, 22 (08) : 1579 - 1587
  • [10] The dimer interface of ERK1/2 provides a potential strategy for selective inhibition of pathological cardiac hypertrophy
    Tomasovic, A.
    Kramer, S.
    Huemmert, M.
    Katus, Ha
    Mueller, O.
    Lorenz, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 187 - 187
12345